Chitosan-Based Biomaterials for Tissue Regeneration
Биоматериалы на основе хитозана для регенерации тканей
2023-03-01
SCID: 54.1/c7quhr3p
Discuss with AI
chitosan-based biomaterialscontrolled drug deliverysustained therapeutic releasetissue regenerationtissue-engineered scaffolds
Figures from the paper
Abstract (AI)
Chitosan is a chitin-derived biopolymer that has shown great potential for tissue regeneration and controlled drug delivery. It has numerous qualities that make it attractive for biomedical applications such as biocompatibility, low toxicity, broad-spectrum antimicrobial activity, and many others. Importantly, chitosan can be fabricated into a variety of structures including nanoparticles, scaffolds, hydrogels, and membranes, which can be tailored to deliver a desirable outcome. Composite chitosan-based biomaterials have been demonstrated to stimulate in vivo regeneration and the repair of various tissues and organs, including but not limited to, bone, cartilage, dental, skin, nerve, cardiac, and other tissues. Specifically, de novo tissue formation, resident stem cell differentiation, and extracellular matrix reconstruction were observed in multiple preclinical models of different tissue injuries upon treatment with chitosan-based formulations. Moreover, chitosan structures have been proven to be efficient carriers for medications, genes, and bioactive compounds since they can maintain the sustained release of these therapeutics. In this review, we discuss the most recently published applications of chitosan-based biomaterials for different tissue and organ regeneration as well as the delivery of various therapeutics.
Key Findings
1
Chitosan can be fabricated into nanoparticles, scaffolds, hydrogels, and membranes, enabling application-specific biomaterial designs.
2
Chitosan combines biocompatibility, low toxicity, and broad-spectrum antimicrobial activity, supporting its potential in tissue regeneration and drug delivery.
3
Chitosan structures efficiently deliver medications, genes, and bioactive compounds by providing sustained therapeutic release.
4
Composite chitosan-based biomaterials have stimulated regeneration and repair of bone, cartilage, dental, skin, nerve, cardiac, and other tissues in preclinical models.
5
Treatment with chitosan formulations has produced de novo tissue formation, resident stem cell differentiation, and extracellular matrix reconstruction after diverse tissue injuries.
Research Object
chitosan-based biomaterials for tissue and organ regeneration and therapeutic delivery
Research Subject
their regenerative effects and sustained-delivery performance, including de novo tissue formation, stem cell differentiation, extracellular matrix reconstruction, and delivery of medications, genes, and bioactive compounds
Publication Details
Publication Date
2023-03-01
Journal
Publisher
ISSN
Cited by
263
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest